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embryonic expression (<E10.5) caused failure of LC neu-
ronal specification and perinatal respiratory lethality. In 
contrast, later onset (E11.5) of PHOX2B∆8 expression was 
not deleterious to LC development and perinatal respira-
tory lethality was rescued, despite failure of chemosensor 
retrotrapezoid nucleus formation. Our findings indicate that 
early-onset mutant PHOX2B expression inhibits LC neu-
ronal development in CCHS. They further suggest that such 
mutations result in dysregulation of central noradrenergic 
signaling, and therefore, potential for early pharmacologic 
intervention in humans with CCHS.
Keywords Congenital central hypoventilation syndrome · 
Locus coeruleus · Noradrenergic system · PHOX2B
Abstract Human congenital central hypoventilation 
syndrome (CCHS), resulting from mutations in transcrip-
tion factor PHOX2B, manifests with impaired responses 
to hypoxemia and hypercapnia especially during sleep. To 
identify brainstem structures developmentally affected in 
CCHS, we analyzed two postmortem neonatal-lethal cases 
with confirmed polyalanine repeat expansion (PARM) or 
Non-PARM (PHOX2B∆8) mutation of PHOX2B. Both 
human cases showed neuronal losses within the locus coer-
uleus (LC), which is important for central noradrenergic 
signaling. Using a conditionally active transgenic mouse 
model of the PHOX2B∆8 mutation, we found that early 
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Introduction
Congenital central hypoventilation syndrome (CCHS) is a 
classic disorder of autonomic respiratory control character-
ized by alveolar hypoventilation and monotonous respira-
tory rates despite abnormal pCO2 and pH concentrations, 
especially during non-rapid eye movement (NREM) sleep 
[57]. Patients with CCHS lack behavioral responsiveness to 
hypoxemia and hypercarbia without symptoms of shortness 
of breath or respiratory distress [8], and will not automati-
cally adjust spontaneous ventilation or awaken from sleep 
despite progressive physiologic compromise [57]. A sub-
set of CCHS patients have Hirschsprung disease (HSCR; 
absence of ganglion cells from variable lengths of distal 
bowel), and/or solid extracranial tumors of neural crest ori-
gin [6, 53], and additional symptoms of autonomic nervous 
system dysregulation are reported [18, 20, 42, 48].
Autonomic respiratory networks are stimulated when 
specialized neuronal sensors (chemosensors) detect low 
levels of O2 and/or high levels of CO2 in the blood. These 
chemosensors include the carotid bodies (CB), located in 
the peripheral nervous system (PNS) near the bifurcation of 
the carotid artery, and several central nervous system (CNS) 
nuclei [22]. Specialized neurons and astrocytic populations 
in brain stem contribute to central CO2 chemosensation [9, 
19]. Classical pharmacological studies show that catecho-
laminergic neuron depletion in the brain stem results in 
decreased ventilatory response to elevated CO2 levels [31]. 
The rodent retrotrapezoid nucleus (RTN), located ventral 
to the facial nerve nucleus, drives respiration in response 
to decreased pH, resulting from elevated blood CO2 con-
centrations [34]. Interestingly, such hypercapnic ventilatory 
responses were diminished in adult rodents after chemical 
ablation of the locus coeruleus (LC) [7], a major central 
noradrenergic structure that is located in dorsal brainstem 
with extensive connections to other local nuclei as well as 
forebrain.
The human paired-like homeodomain transcription fac-
tor PHOX2B contains C-terminal 9- and 20-alanine repeats 
(Fig. 1a). Heterozygous mutations of PHOX2B are etiologic 
in CCHS [1, 59], comprising polyalanine repeat expansion 
mutations (PARMs; 90–92 % of cases) in exon 3, as well as 
non-PARMs with missense, frameshift, nonsense and stop-
codon mutations (NPARMs; 8–10 % of cases) throughout 
the coding region, and whole- or partial-gene deletions 
(<1 % of cases) [27]. A genotype–phenotype correlation 
has been shown between PHOX2B polyalanine repeat 
length and severity of the respiratory phenotype, associ-
ated symptoms, and the age of onset [2, 33, 58, 59]. Large 
heterozygous NPARM deletions within exon 3 are corre-
lated with the most severe CCHS phenotype with complete 
apnea and/or profound hypoventilation during sleep, severe 
hypoventilation during wakefulness, and intestinal agangli-
onosis from duodenum to anus [6, 33, 53].
In rodents, RTN development requires Phox2b func-
tion [12], and mouse models of CCHS, either expressing 
the 27-polyalanine repeat PARM or NPARM mutations of 
Phox2b, prevent RTN formation [13, 35]. Although Phox2b 
is a well-known regulator of motor and noradrenergic neu-
ronal specification [39, 40], the precise basis of respiratory 
control in CCHS remains incompletely understood. Indeed, 
abnormal development or injury to central noradrenergic 
structures is suggested by prior work. The LC is the major 
source of central noradrenergic signaling [5]; it is thus a 
major regulator of arousal state and is also thought to func-
tion in cognition [49]. Several lines of evidence support the 
role of LC as a central chemosensor [11, 17], but owing 
to the lack of neuropathological information from CCHS 
patients with confirmed PHOX2B mutations, it remains 
unclear whether CCHS-associated PHOX2B mutations pri-
marily affect LC development.
To achieve further insight into the pathobiology of 
CCHS, we analyzed two postmortem cases of neonatal-
lethal CCHS with confirmed PHOX2B mutations. Proband 
1 was a full-term neonate with a heterozygous NPARM 
deletion/frameshift mutation (PHOX2B∆8), resulting in 
severe hypoventilation and total intestinal aganglionosis. 
Proband 2 was born preterm and had the most common het-
erozygous CCHS PHOX2B 20/27 mutation (PARM) with 
less severe phenotype. Interestingly, both cases showed 
loss or severe diminishment of noradrenergic LC neurons. 
We modeled the NPARM case in vivo by generating a cog-
nate conditional transgenic mouse line. Early embryonic 
conditional activation of Phox2b∆8 in mouse brainstem 
(<E10.5) caused loss of a functional LC and abnormali-
ties in all central noradrenergic (NA) neurons (e.g., A1/C2, 
forebrain projections to hypothalamus) tested. In contrast, 
later-onset (E11.5) activation of Phox2b∆8 expression 
spared NA neuron development and was not perinatal res-
piratory-lethal, despite loss of the RTN. Our findings dem-
onstrate that LC development is compromised, and suggest 
abnormal central noradrenergic signaling, as a component 
of human CCHS.
Materials and methods
Human neuropathological studies
Postmortem human samples (proband 1) were obtained 
using University of California, San Francisco (UCSF) 
guidelines with oversight of the Committee for Human 
Research and Gamete, Embryo and Stem Cell Research 
(GESCR) committee. Tissue from PHOX2B 20/27 proband 
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2 was obtained from Rainbow Babies and Children’s Hos-
pital (Cleveland, OH, USA) under an IRB-approved proto-
col at The Ohio State University. The entire formalin-fixed 
brainstems were serially sectioned for microscopic evalua-
tion and compared to samples obtained from four roughly 
age-matched (control) patients that expired from other 
diseases. For case histories of controls, histological and 
immunohistochemical (IHC) procedures, see Suppl. Data.
Phox2b∆8 mouse model generation and animal 
husbandry
We generated a transgenic mouse line carrying a cre–loxP-
inducible allele of human PHOX2B∆8 exon 3 by BAC 
recombineering and homologous recombination in embry-
onic stem cells (ES cells; See Suppl. Data). For early-onset 
(germline) activation of Phox2b∆8 allele, Hprt-cre mice 
(JAX 004302 on C57/Bl6 background) were intercrossed 
to Phox2b∆8 heterozygotes. For late-onset CNS activation 
of Phox2b∆8 allele, we used Blbp-cre [23]. Mutant mice 
in each genotype were compared to cre-negative litter-
mate controls. Animal procedures were approved by Insti-
tutional Animal Care and Use Committees at Washington 
University (St. Louis, MO, USA), University of Connecti-
cut Health Center (Farmington, CT, USA) and UCSF (San 
Francisco, CA, USA).
Mouse tissue processing, and histology
Embryos were collected from time-pregnant females (E0.5 
at time of plug recognition) under deep anesthesia; those 
older than E16.5 were perfused with PBS followed by 
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Fig. 1  Genotype and respiratory physiological phenotypes of the 
proband and transgenic mouse model. a PHOX2B contains three 
exons and proband 8-nucleotide frameshift mutation in exon 3 is 
shown. Nucleotide number refers to nucleotide position of Gen-
Bank accession number CCDS 3463.1. Wild-type PHOX2B protein 
is 314 amino acids long; PHOX2B∆8 mutation results in loss of the 
20-alanine repeat domain and generates a protein of 355 amino acids. 
b Polysomnographic recording from the proband while on Synchro-
nized Intermittent Mandatory Ventilation (SIMV) and after switch-
ing to continuous positive airway pressure (CPAP). Note the rapid 
decrease in oxygen saturation (blue arrow) and increase in carbon 
dioxide (pink arrow) levels. Values of ETCO2 at each epoch shown. 
When challenged with persistent hypercarbia and hypoxemia during 
CPAP, the proband showed no increase in respiratory effort. Heart 
rate variability during the challenge was minimal. EKG electrocar-
diogram, SpO2 oxygen saturation, ETCO2 end-tidal CO2, Nasal nasal 
airflow, Chest chest wall movements from respiratory inductance ple-
thysmography. CPAP pressure of 5 cm H2O was used. SIMV rate was 
45 breaths/min. “Early” refers to 45 s after switching to CPAP, “late” 
refers to 75 s after switching to CPAP. Time scale is shown. c Tar-
geting construct of patient-specific mouse model. Human PHOX2B 
exon 3 containing patient-specific PHOX2B mutation (denoted in 
blue color) is inserted following unmodified, non-mutated mouse 
Phox2b exon 3 flanked by loxP sites, to allow conditional expression 
of mutant gene by cre recombinase. For detailed generation of trans-
genic mouse line see Figure S4. d Endogenous respiratory output. 
Integrated C4 inspiratory activity from E18.5 control and Hprt-cre, 
Phox2b∆8 mutant mice under baseline (left) and stimulated (1 μM 
substance P, right) conditions. Note lack of response in Phox2b∆8 
mouse brainstem (n = 4, a representative recording shown)
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4 % PFA under hypothermia anesthesia. For IHC, tissues 
were post-fixed in 4 % PFA and cryoprotected, frozen in 
OCT and sectioned at 14 μm. Cryosections were subjected 
to antigen retrieval in citrate buffer, pH 6.0 for 10 min at 
90 °C as necessary, blocked with 5 % donkey serum in PBS 
with 0.3 % Triton X-100, incubated with primary antibod-
ies overnight at 4 °C, followed by appropriate secondary 
antibodies (see Suppl. Data) for 1 h at room temperature 
prior to imaging on a Nikon 80i microscope equipped with 
Hamamatsu CCD camera.
In vitro mouse explant respiratory physiology
In vitro explant respiratory physiology was performed as 
described [26]. Brainstem–spinal (en bloc) preparations 
with an anterior transection near diencephalon–midbrain 
junction were made using E18.5 embryos as detailed in 
Suppl. Data.
Quantifications and statistical analysis
All statistical analysis was performed using Microsoft 
Excel (Mac Office 2008) or R version 2.11.1. Transgenic 
mouse phenotypes were analyzed with Student’s t test.
Results
Human CCHS proband 1: clinical history 
and neuropathological findings
A full-term male presented with respiratory depression 
at birth, apnea and oxygen desaturation that required 
mechanical ventilation. Polysomnography demonstrated 
normal baseline oxygen saturation (SpO2) and end-tidal 
CO2 (ETCO2) while mechanically ventilated (Fig. 1b, 
Figure S1). However, when challenged by removal of the 
ventilator-generated respiratory rate, proband 1 showed 
hypoventilation resulting in oxygen desaturation (nadir 
57 %) and rise of ETCO2 (peak 82 mmHg) during both 
wakefulness and sleep. Persistent and profound hypox-
emia and hypercapnia failed to induce chemoreceptor 
reflexes (i.e., increased breathing rate/effort or a varia-
tion of heart rate); there was no arousal response from 
sleep (Fig. 1b, Figure S1). Magnetic resonance imaging 
and spectroscopy of the brain were normal. The electro-
encephalogram showed normal brain activity, both dur-
ing wakefulness and sleep, without seizures. Proband 
1 had permanently dilated pupils with non-measurable 
response to light, suggesting autonomic dysfunction. 
Because of enteral feeding intolerance, he was depend-
ent on total parenteral nutrition. The intestine showed 
pervasive aganglionosis from 10 cm distal to the 
ligament of Treitz to the rectum (Figure S2), indicating 
HSCR disease.
Genomic DNA analysis demonstrated an eight-nucleo-
tide deletion in exon 3 of PHOX2B (Fig. 1a; cDNA position 
691-GGCCCGGG-698; heretofore called PHOX2B∆8). 
This caused a frameshift that removed the alanine repeat-
generated elongated aberrant residues from amino acid 230 
to the C-terminus (Figure S3a). Maternal DNA showed 
intact copies of PHOX2B; however, our analysis does not 
rule out possible low-level somatic mosaicism [28]. Pater-
nal DNA was unavailable. Together, these clinical, genetic, 
and pathological findings confirmed a NPARM PHOX2B 
mutation and diagnosis of CCHS with intestinal agangli-
onosis. Following withdrawal of life support at 6 weeks of 
age, an autopsy was performed.
Postmortem examination showed a dramatic loss of 
LC neurons that express dopamine β-hydroxylase (DBH) 
(Fig. 2a, b). The dorsal median raphe (dMnR), a major 
source of central serotonergic innervation, was severely 
diminished. We found additional losses of the hindbrain 
mesencephalic trigeminal nucleus (MesV) and dorsal 
motor nucleus of the vagus (DMNV), which derive from 
Phox2b+ progenitors [12, 24] (Fig. 2a, b; Table S1). In 
contrast, there were no gross or microscopic abnormali-
ties detectable in cerebral cortex, striatum or thalamus (not 
shown), or significant abnormalities of the medullary arcu-
ate nucleus, CNVII (facial nucleus), or surrounding areas 
including inferior olive, area postrema or nucleus preposi-
tus (Figure S3b).
Dysregulated brain stem development in PHOX2B∆8 
conditional mouse model
To assess function of PHOX2B∆8 during development in 
vivo, we generated a conditional transgenic mouse line by 
targeted homologous recombination in ES cells (Fig. 1c). 
Note because human and mouse exon 3 are identical at the 
amino acid level we used mutant human exon 3 for con-
ditional expression of PHOX2B∆8 in mouse. In this line, 
the engineered PHOX2B∆8 allele is activated by bacteri-
ophage P1 cre recombinase, which initiates expression of 
PHOX2B∆8 proteins and a downstream green fluorescent 
protein (GFP) reporter gene, as shown in Figure S4a.
We crossed this line with the germline driver Hprt-cre 
to activate recombination in all tissues from early embry-
onic stages. In PHOX2B∆8 mutant mice, we first con-
firmed faithful reporter GFP expression in all known 
Phox2b-expressing regions (e.g., hindbrain nuclei, enteric 
neurons) using co-labeling with an antibody for the unmu-
tated N-terminal region of Phox2b protein (Figure S4b). No 
GFP expression was observed in WT littermates. Finally, 
we used IHC with an antibody for the C-terminal region 
of Phox2b protein (a region affected by PHOX2B∆8 
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mutation) to confirm expression of the non-mutant allele 
in heterozygotes (not shown). These findings confirmed all 
expected characteristics of PHOX2B∆8 expression in vivo.
Heterozygous Hprt-cre, Phox2b∆8 pups showed perina-
tal lethality and died before P1. Harvest just prior to birth 
at embryonic day 18.5 (E18.5) revealed that only 33 % of 
mutants took one spontaneous breath (vs. 100 % in con-
trol, n = 8 mutants, 15 controls). No mutants showed fur-
ther spontaneous respiratory effort; thus, all died within 
minutes of delivery. Electrophysiological recording from 
E18.5 ex vivo brain stem preparations showed depression 
of endogenous respiratory motor root output under baseline 
conditions and in response to the excitatory neuropeptide, 
substance P, confirming abnormal respiratory phenotype in 
Hprt-cre, Phox2b∆8 mice (Fig. 1d), in keeping with other 
mouse models of CCHS [14, 26, 44, 54].
Abnormal noradrenergic structures in brainstem 
of Hprt‑cre, Phox2b∆8 mice
Generation of a patient-specific NPARM CCHS mouse 
model and findings from our human proband provided 
an opportunity for cross-species analysis to identify con-
served neuropathological features (Table S1, Figs. 2, 3). 
In the mouse, we observed that the LC was also abnormal 
and failed to express tyrosine hydroxylase (TH), indicat-
ing a synthetic defect in noradrenergic pathway (Fig. 3a). 
Absence of TH neurons within the LC was correlated with 
sparse and small neuronal cell bodies, suggesting cel-
lular loss/attrition rather than selective reduction of TH 
expression (Figure S5a). In addition, we observed con-
sistent losses in the DMNV and mesencephalic trigeminal 
nucleus nuclei (MesV) (Fig. 3c, d). Neuronal precursors of 
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Fig. 2  Brainstem pathology in CCHS probands. a Cartoon of human 
hindbrain at levels of pons (pink) and medulla (blue) is shown. b Dra-
matic losses were observed in NPARM PHOX2B∆8 proband locus 
coeruleus (LC), dorsal median raphe (MnR), mesencephalic trigemi-
nal nucleus (MesV) and dorsal motor nucleus of vagus (DMNV). 
Note lack of dopamine β-hydroxylase (DBH) expression in LC and 
tryptophan hydroxylase (TrypH) in dorsal MnR indicating defects in 
synthesis of noradrenaline and serotonin production. DMNV showed 
diminished cholinergic neurons, indicated by choline acetyltrans-
ferase (CHAT) expression. Asterisk indicates diminished MesV fib-
ers originating from the nucleus in the proband. H&E hematoxylin 
and eosin. c Dramatic loss was observed in PARM PHOX2B 20/27 
proband LC. Note a significant reduction of DBH expression
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the DMNV were detectable at E13.5 (Figure S5b) in the 
mouse model, suggesting PHOX2B∆8 prevents DMNV 
formation despite progenitor specification. In contrast, 
while the dMnR showed severe attrition in the human 
proband (Fig. 2b), we found normal-appearing popula-
tions of serotonergic neurons that expressed tryptophan 
hydroxylase (17.00 ± 2.81 SEM (mutant) vs. 16.75 ± 2.79 
SEM (control) cells per area, p = 0.812, n = 3) and 5HT 
(25.58 ± 9.13 vs 23.08 ± 1.88 cells per area, p = 0.952, 
n = 3, Student’s t test) spanning murine dMnR (Fig. 3b). 
No gross abnormalities in forebrain were observed. In sum-
mary, abnormal development of the LC was prominent con-
sistently across species.
PHOX2B∆8 inhibits LC noradrenergic neuronal 
specification
The LC is the major source of noradrenergic neuro-
transmitters in the CNS [5], and it projects to circuits in 
forebrain, midbrain and hindbrain [45]. As shown (Figs. 3a, 
4b), early activation of PHOX2B∆8 in the brainstem of 
Hprt-cre, Phox2b∆8 mice resulted in developmental fail-
ure of TH + LC neurons. As we observed normal-sized 
populations of Phox2b-GFP+ precursors (Fig. 4a, dis-
cussed below), we conclude that early-onset PHOX2B∆8 
expression inhibits LC specification. Consistent with this, 
we observed widespread abnormalities in noradrenergic 
circuits, including caudal hindbrain nuclei A1/C2 and the 
forebrain projections of LC to hypothalamus (Fig. 4b, A1/
C2 in Figure S5c).
Our conditional Phox2b∆8 mouse model and cre-driver 
lines permitted introduction of PHOX2B∆8 at two dis-
tinct time points in noradrenergic neuronal development. 
Whereas Hprt-cre introduces the mutation in the early 
embryo (<E10.5), Blbp-cre [23] results in CNS-restricted 
activation of the conditional PHOX2B∆8 allele at E10.5 
and later, after most neurogenesis. Fate mapping, using the 
conditional reporter function of the PHOX2B∆8 mutant 
Fig. 3  Brain pathology in 
Hprt-cre, Phox2b∆8 mouse. 
Top Cartoon of mouse hindbrain 
at levels of rostral (pink) and 
caudal (blue) hindbrain is 
shown. a–d The Hprt-cre, 
Phox2b∆8 mutant mouse 
showed profoundly abnormal 
differentiation of LC, charac-
terized by absent expression 
of tyrosine hydroxylase (TH). 
Additional abnormalities were 
diminished MesV (Brn3) and 
DMNV Choline Acetyltrans-
ferase (CHAT) neurons. In con-
trast to NPARM PHOX2B∆8 
proband (see Fig. 2b), the dorsal 
MnR in Hprt-cre, Phox2b∆8 
mouse showed non-significant 
reduction in counts of TrypH 
and 5HT cells compared with 
controls (n = 3). V, 4th ventri-
cle. Scale bar unit µm
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locus (Fig. 1c), showed robust onset of GFP expression in 
Phox2b+ cells at E10.5 with Hprt-cre, but only confined 
GFP+ population in Blbp-cre fate-mapped hindbrain (Fig-
ure S5d). In contrast, Blbp-cre targeting in brainstem was 
robust after E11.5 (Fig. 4a). Differences in prenatal viabil-
ity between these two lines were noted (Figure S5e).
We next assessed consequences of early (<E10.5) ver-
sus later onset (>E11.5) of PHOX2B∆8 expression for 
LC development. As shown (Fig. 4a), at E10.5 TH+, pre-
sumptive noradrenergic neurons were detectable in LC of 
control mice; moreover, these cells co-expressed Phox2b, 
consistent with previous findings [24]. Such TH+ popula-
tions were absent in the early-onset Hprt-cre, Phox2b∆8 
mice. Contrasting this, the late-onset Blbp-cre, Phox2b∆8 
model showed normal LC TH+ populations co-expressing 
Phox2b (Fig. 4a, b). The TH+, Phox2b+ populations did 
not express GFP, suggesting these cells expressed wild-
type Phox2b allele. Together, these findings suggest that 
PHOX2B∆8 inhibits LC noradrenergic differentiation in a 
stage-specific manner. That is, early-onset mutant protein 
expression derails LC differentiation in a dominant-toxic 
manner, whereas later-stage expression of the PHOX2B∆8 
allele does not interfere with acquisition of TH expression 
in Phox2b+-derived LC neurons.
RTN development is uncoupled from the perinatal 
respiratory‑lethal phenotype of PHOX2B∆8 mice
We observed striking differences in the perinatal respira-
tory phenotype of early-onset Hprt-cre, Phox2b∆8 versus 
late-onset Blbp-cre, Phox2b∆8 models (Fig. 5). As men-
tioned above, Hprt-cre, Phox2b∆8 animals showed little/
E11.5
GFP TH
r1
Control 
E10.5 E18.5-P0
TH THTH
A1LC HypothalamusLC
GFP TH Phox2b
Hprt-cre, 
Phox2b∆8
Blbp-cre, 
Phox2b∆8
(a) (b)
Fig. 4  Noradrenergic neurons are affected by stage-specific activa-
tion of PHOX2B∆8. a Left panels the specification of noradrener-
gic neurons in LC appears by E10.5 in control, which express TH in 
addition to Phox2b. In Hprt-cre fate-mapped early-onset mice, the 
TH expression is diminished despite available Phox2b+ precursors. 
Note expression of PHOX2B∆8 protein (GFP+) in the same cells. 
Blbp-cre fate-mapped late-onset mice showed normal TH expressions 
and PHOX2B∆8 is not expressed. Right panels by E11.5, cre-activa-
tion in late-onset mice commences in noradrenergic neurons, shown 
by GFP+ (n = 3–4). Note that mouse E10.5 and E11.5 are roughly 
equivalent to human gestational age week 6 and week 7, respectively. 
b Central noradrenergic neurons affected by early-onset Hprt-cre, 
Phox2b∆8 were pervasive at E18.5 C-section including hindbrain 
nuclei LC and A1 and forebrain projection to periventricular nucleus 
of the hypothalamus. In the late-onset Blbp-cre, Phox2b∆8, noradr-
energic neurons were intact in all areas at P0 (n = 3)
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no spontaneous respiratory effort, rapidly became cyanotic 
(dark violet skin tone) and died minutes after birth (Fig. 5b, 
e–f). In contrast, Blbp-cre, Phox2b∆8 mice were typically 
pink (non-cyanotic) and showed spontaneous/continuous 
breathing (albeit at slightly reduced frequency; 78 ± 8.5 % 
of control respiratory rate, n = 3, p > 0.1, Student’s t 
test) (Fig. 5c, e–f). Longitudinal observation of Blbp-cre, 
Phox2b∆8 mice past P1 was not possible, as the mutants 
failed to nurse and gain adequate body weight.
One possibility to account for these differences 
was differential effects of early versus late Phox2b∆8 
expression on RTN development [34]. However, histo-
logical examination of the brainstems from both Hprt-
cre- and Blbp-cre-driven models showed loss of RTN 
and CNVII nuclei, as shown by IHC and quantitative 
analysis of the markers Phox2b, Islet1 and neurokinin 
1 receptor (NK1R) (Fig. 5a–d). Moreover, develop-
mental analysis of embryonic brainstem confirmed that 
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Fig. 5  Central chemosensor RTN and CNVII are dispensable for per-
inatal respiratory regulation. a–c Respiratory phenotype and central 
chemosensor of a control, b early-onset Hprt-cre, Phox2b∆8, and c 
late-onset Blbp-cre, Phox2b∆8 mice. Whereas Hprt-cre, Phox2b∆8 
mice failed to show any respiratory effort, were cyanotic (dark vio-
let skin tone), and died in the immediate perinatal period, Blbp-cre, 
Phox2b∆8 mice showed spontaneous respiration and were pink 
(n = 7–11 from at least 3 litters/genotype). Both Hprt-cre, Phox2b∆8 
and Blbp-cre, Phox2b∆8 mice lacked the central chemosensor RTN 
(Phox2b+/Islet−, and NK1R+/Phox2b+) and CNVII (Phox2b+/
Islet+), despite continuous respiration in Blbp-cre, Phox2b∆8 and 
lack of respiration in Hprt-cre, Phox2b∆8 (n = 3). d Quantification 
of RTN (Phox2b+/Islet−) and CNVII (Phox2b+/Islet+) showed sig-
nificant losses of both nuclei at E18.5 (n = 3). e When mice were 
harvested at E18.5, no Hprt-cre, Phox2b∆8 mice showed continu-
ous respiration in contrast to Blbp-cre, Phox2b∆8 and control mice 
(n = 7–11 from at least 3 litters/genotype). f Quantification of breath-
ing rate at birth showed spontaneous/continuous breathing in Blbp-
cre, Phox2b∆8 mice albeit at reduced frequency. Respiratory rate 
ranged 20–132 breaths/min depending on time post-birth, normalized 
to control within the same litter (n = 3–5). N/A not assessed due to 
absence of respiration
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abnormal formation of CNVII was due to failure of 
precursor migration in the Hprt-cre, Phox2b∆8 mouse 
model (Fig. 6a–c), in keeping with reported findings 
in other CCHS mouse models [10, 13, 26, 35]. A simi-
larly mis-located putative CNVII was found in Blbp-
cre, Phox2b∆8 mouse (Figure S5f). Analysis of MnR in 
Blbp-cre, Phox2b∆8 mouse showed normal number of 
serotonergic neurons expressing TryptH (17.833 ± 1.815 
SEM cells per area, p = 0.682, n = 3, and 5HT (Figure 
S5g) (27.166 ± 1.249 SEM cells per area, p = 0.793, 
n = 3, Student’s t test). Thus, our findings in late-onset 
Blbp-cre, Phox2b∆8 mice indicate that the RTN is dis-
pensable for generation of minimal perinatal respiratory 
rhythm, in keeping with the proposal that self-evoked 
respiration is possible without the RTN [26, 44].
Human CCHS proband 2: clinical history 
and neuropathological findings
Proband 2 was a 27 5/7-week gestation age preterm infant 
male. He was intubated at birth due to poor respiratory 
effort and received surfactant. Although there was no evi-
dence for chronic lung disease of prematurity, the patient 
remained ventilator dependent. At approximately 4 weeks 
of age, lack of respiratory drive despite persistent hyper-
capnia prompted genetic testing for CCHS. Proband 2 car-
ried a heterozygous PARM PHOX2B mutation, resulting in 
the most common, 7-residue alanine expansion (PHOX2B 
20/27 genotype). After withdrawal of life support at ~41-
week corrected gestational age, autopsy was performed 
with postmortem analysis of brainstem.
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Fig. 6  Abnormal migration of facial nucleus CNVII in Hprt-cre, 
Phox2b∆8 mouse. a Neurons of CNVII migrate caudally from their 
origin in rhombomere (r)4 toward r6 followed by lateral migra-
tion toward ventral surface. Horizontal sections at E11.5 to visual-
ize trans-rhombomere migration showed in Hprt-cre, Phox2b∆8 
mouse, precocious termination of rostral-to-caudal migration (note 
accumulation of Phox2b+ Islet1+ cells at r4–5), and abnormal lat-
eral migration within r4–5 (arrowheads) (V 4th ventricle, A anterior, 
P posterior, L lateral, M medial). b Top cartoon of mouse hindbrain 
levels of rostral (R) and caudal (C) at E14 is shown. At E13.5, stalled 
migration of CNVII/RTN, detected by Islet1 and Phox2b antibodies, 
was found at rostral levels (denoted by solid arrowheads) of hind-
brain than normally found at caudal level (denoted by empty arrow-
heads) in control littermates. c The same pattern described in b was 
observed at E15.5, implicating permanent migration defect of CNVII. 
The number of putative Phox2b+ Islet1+ CNVII cells found in the 
mutants declined from 37.6 to 16.2 % of WT at E13.5 and E15.5, 
respectively. Scale bar unit µm
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While the pons contained a cluster of cells morphologi-
cally and anatomically consistent with the LC, as shown 
in Figs. 2c and S6, they failed to express normal levels of 
DBH or TH, indicating LC dysfunction and noradrenergic 
synthesis. We did not observe gliosis or other signs indica-
tive of hypoxic damage in the brain stem. In contrast to the 
NPARM PHOX2B∆8 CCHS proband 1 (Fig. 2b), the MnR, 
MesV, and DMNV hindbrain nuclei in the PARM subject 
appeared normal (Figure S6). Taken together, our findings 
indicate that both NPARM and PARM PHOX2B mutations 
result in defects of LC neuronal populations in human neo-
nates with CCHS.
Discussion
The underlying pathobiology of CCHS remains unclear, 
reflecting in part the complexity of central and peripheral 
centers that interact to control respiratory drive. We used 
a combinatorial approach incorporating human neuropatho-
logical analysis from two (NPARM and PARM) human 
probands and a conditionally activated NPARM patient-
specific transgenic mouse model to study temporal effects 
of mutant protein on brainstem development. Our study is 
the first to describe CNS neuropathological findings in two 
human cases of CCHS with confirmed PARM and NPARM 
mutations of PHOXB2B, which are summarized in Table 
S1. Further, we modeled the proband-specific NPARM 
mutation introduced at several stages of mouse hindbrain 
development. While several structures are affected vari-
ously in these cases, a focus on conserved abnormalities 
between species revealed abnormalities in LC populations, 
which probably result from failure to specify LC neurons in 
the embryonic brain. Our findings suggest that disruption 
of LC noradrenergic neuron development and function may 
be a common pathobiological feature of CCHS.
Brainstem pathological findings in two human CCHS 
cases with confirmed NPARM and PARM PHOX2B 
mutations
The LC is the major source of noradrenergic innervation to 
both rostral brain regions as well as the brainstem. Abnor-
mal noradrenergic signaling has been implicated in clini-
cal features of CCHS [32, 55]. Studies of CCHS by diffu-
sion MRI (albeit without confirmed PHOX2B mutations) 
showed altered diffusivity (decreased fractional anisotropy 
and increased axial and radial diffusivity) in several brain-
stem regions as well as other potentially connected regions 
of the mid-hindbrain [41]. Such late structure/function 
studies in adolescents carry the caveat that injury to LC 
or dMnR could have accrued from cumulative effects of 
repeated episodes of hypoxemia.
In contrast, the two NPARM and PARM probands we stud-
ied were neonates that were intubated and/or managed in an 
NICU from birth with stringent monitoring and interventions 
to prevent hypoxemic events after birth. Proband 1 carried a 
NPARM mutation of (PHOX2B∆8) and demonstrated severe 
CCHS and intestinal aganglionosis (Haddad syndrome). Post-
mortem analysis showed several brainstem nuclei were abnor-
mal (Table S1) including almost total absence of LC neurons. 
Furthermore, a second PHOX2B 20/27 PARM proband 2 also 
showed defects in DBH and TH expression in the context of a 
well-formed LC, indicating deficient numbers of functioning 
noradrenergic neurons. The correspondence of abnormalities 
in the LC in both human cases is striking. While further con-
firmation in additional cases of CCHS would be useful, such 
pathological specimens in confirmed cases of neonatal CCHS 
with PHOX2B mutation are extremely rare. We note these data 
are consistent with a previously reported case of CCHS (albeit 
without a confirmed PHOX2B mutation), showing significant 
defects in noradrenergic cell number [52]. Together, these 
findings suggest that abnormal development of the LC is com-
mon in CCHS.
NPARM PHOX2B∆8 permits brainstem noradrenergic 
neuron precursor allocation but inhibits differentiation 
in a stage‑restricted manner
Our findings demonstrate that inhibitory effects of PHOX2B∆8 
proteins during LC development are stage restricted. The murine 
LC is formed during E9–E11 [50] and by E11.5 it is a clearly 
identifiable structure [3]. Human equivalent developmental 
stage for mesencephalic TH neurons occurs 6.5–8 weeks post-
conception [16, 36]. We found that early mutant protein expres-
sion (using Hprt-cre) prevented LC neuron specification/differ-
entiation to a TH+ state. In contrast, delayed expression of the 
mutation (with Blbp-cre) permitted LC neuron differentiation to 
the TH+ stage. Together, these findings indicate PHOX2B∆8 
proteins inhibit early LC neuronal specification, rather than the 
program of expression characteristic of mature LC neurons.
Abnormal respiratory arousal during NREM sleep is 
associated with dysregulation of central adrenergic [38] 
and serotonergic [25, 43] signaling. Caudally, the LC 
densely innervates the serotonergic dorsal raphe nucleus 
[30]. The dorsal raphe nucleus does not express PHOX2B. 
Therefore, the finding in human proband 1 that the dorsal 
raphe was lost is consistent with the possibility of long-
term failure of normal feedback mechanisms. For example, 
classical ultrastructural studies have demonstrated in exper-
imental animals innervation of serotonergic neurons by 
noradrenergic locus coeruleus neurons [4]. This circuitry 
between noradrenergic and serotonergic systems raise the 
possibility that disease affecting the noradrenergic system 
could cause secondary effects to the serotonergic neurons 
through transneuronal degeneration mechanisms similar to 
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neurodegenerative diseases [15]. In keeping with this pos-
sibility, the NPARM early-onset mouse model did not show 
defects in the dMnR. Moreover, we observed that noradren-
ergic circuit formation in hypothalamus and A1/C2 nuclei 
of brain stem were also rescued in the Blbp-cre, Phox2b∆8 
mice, suggesting that PHOX2B∆8 generally exerts its 
impact on noradrenergic neuron development at an early 
stage. Further work is needed to identify precise gene tar-
gets affected in the early-onset phenotype (see discussion 
below).
Evidence that RTN is dispensable for perinatal 
respiratory drive in the NPARM CCHS model
The RTN is generally thought to have critical roles in 
perinatal respiratory control in rodents [21]. However, 
while conditional targeting of Phox2b function resulted 
in failure of RTN development and lethal respiratory 
compromise in one study [14], another study that selec-
tively targeted disruption of the RTN with Egr2-cre did 
not cause perinatal respiratory lethality and suggested 
its importance might be specific to chemosensation [44]. 
We found that while late-onset PHOX2B∆8 expression 
caused failure of RTN and CNVII development, animals 
showed near-normal perinatal respiration, indicating dis-
pensability of the RTN for this function. Unfortunately, 
such Blbp-cre, PHOX2B∆8 animals did not survive past 
P1 due to oropharyngeal problems preventing feeding 
and so further testing was not performed. Nevertheless, 
our studies suggest the RTN is dispensable as an early 
regulator of respiratory drive. In the human, the equiva-
lent structure to RTN has been suggested [29, 47], but 
its existence remains controversial. Despite exhaustive 
efforts, we failed to identify an RTN-like structure in our 
proband cases or specimens from five age-matched unaf-
fected subjects, and the facial nucleus (CNVII) was nor-
mal in appearance in the human PHOX2B∆8 proband 
(Figure S3b).
Dysregulation of locus coeruleus development might be 
general feature of human CCHS
Understanding mechanisms that underlie CCHS has gen-
eral implications for development of human respiratory 
control [22] and other disorders of respiratory and auto-
nomic regulation including Rett Syndrome [37], sudden 
infant death syndrome (SIDS) and apnea of prematu-
rity. Findings from two human CCHS cases indicate that 
NPARM and PARM PHOX2B mutations disrupt devel-
opment of LC noradrenergic populations, a finding that 
is phenocopied in the NPARM CCHS mouse model we 
generated, but not in another previously reported mouse 
model of PHOX2B 20/27 PARM [13], which failed to 
show defects in the LC. Why the mouse PHOX2B 20/27 
model fails to capture aberrant LC neuron differentiation 
is unclear, but might reflect differences between mouse 
and human development in the context of 20/27 PARM 
mutations.
Several lines of evidence support the role of LC as 
a central chemosensor [17]. First, Phox2a function is 
required for differentiation of LC but leaves other noradr-
energic centers (locus subcoeruleus and groups A7, A5, 
A2 and A1) intact, and loss of Phox2a function results in 
depressed central respiratory drive [60]. Thus, it is pos-
sible that mutant PHOX2B proteins act in a “dominant-
negative” fashion to inhibit LC neuron specification. Sec-
ond, loss of the LC is associated with markedly decreased 
breathing frequency [56]. Third, in a mouse model of 
Rett syndrome, caused by mutations of methyl-CpG-
binding protein 2 (MECP2), there is loss of LC neurons 
[46, 51], and breathing dysfunction with decreased CO2 
chemosensitivity [61]. Together, these findings suggest 
that LC dysfunction might explain, at least in part, cen-
tral CO2 chemo-insensitivity in CCHS as well as failure 
of normal respiratory arousal. Further research is needed 
to evaluate the utility of pharmacological approaches that 
might target noradrenergic signaling imbalance so that 
the deleterious effects of PHOX2B mutations on CCHS 
patients are attenuated. Indeed, maturational decrement 
in ventilatory slope in response to hypercarbia/hypoxia 
is observed in CCHS [8] suggesting that early pharma-
cologic noradrenergic stimulation might assuage disease 
progression.
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